Angiotensin‐Converting Enzyme Inhibitors or Angiotensin Receptor Blockers Use and COVID‐19 Infection Among 824 650 Patients With Hypertension From a US Integrated Healthcare System

Angiotensin‐Converting Enzyme Inhibitors or Angiotensin Receptor Blockers Use and COVID‐19 Infection Among 824 650 Patients With Hypertension From a US Integrated Healthcare System

Background Previous reports suggest that the use of angiotensin‐converting enzyme inhibitors (ACEIs) or angiotensin receptor blockers (ARBs) may upregulate angiotensin‐converting enzyme 2 receptors and increase severe acute respiratory syndrome coronavirus 2 infectivity. We evaluated the association...

Full description

Bibliographic Details
Main Authors: Jaejin An, Rong Wei, Hui Zhou, Tiffany Q. Luong, Michael K. Gould, Matthew T. Mefford, Teresa N. Harrison, Beth Creekmur, Ming‐Sum Lee, John J. Sim, Jeffrey W. Brettler, John P. Martin, Angeline L. Ong‐Su, Kristi Reynolds
Format: Article
Language:English
Published: Wiley 2021-02-01
Series:Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Subjects:
angiotensin‐converting enzyme inhibitors
angiotensin receptor blockers
COVID‐19
hypertension
Online Access:https://www.ahajournals.org/doi/10.1161/JAHA.120.019669

Internet

https://www.ahajournals.org/doi/10.1161/JAHA.120.019669

Similar Items